Urinary NTX results rarely alter the clinical management of patients with osteoporosis in the tertiary hospital

M.J. Gillett, Samuel Vasikaran

    Research output: Contribution to journalArticle

    4 Citations (Scopus)

    Abstract

    Aim: Urinary levels of cross-linked N-terminal telopeptide of type I collagen ( NTX) are used as a marker of bone resorption and are useful for monitoring response of patients treated with anti-resorptive agents. We aimed to determine how urinary NTX results alter clinical decision making by physicians treating patients with osteoporosis in a tertiary hospital setting.Methods: We reviewed patient notes of all new NTX requests in 2002 and 2003 with at least one subsequent repeat measurement. Patients with a diagnosis of osteoporosis and both pre- and post- treatment measurements of bone mineral density ( BMD) and NTX were included. Urinary NTX was measured with the Osteomark enzyme-linked immunosorbent assay. BMD of the hip and lumbar spine was measured using dual energy X-ray absorptiometry ( DEXA).Results: A total of 357 patients had serial NTX requests during the time period. Sixty-five of these patients had a diagnosis of osteoporosis. Out of 37 patients treated for osteoporosis who had complete data available, 29 patients had concordant results between BMD and NTX and eight patients had discordant results. Only one patient had treatment changed as a result of a lack of reduction in NTX following treatment. Thirteen patients had therapy altered. Common reasons for altering therapy were patient noncompliance, side effects and failure of BMD to increase.Conclusions: Alteration to therapy in this patient population is mainly dictated by issues such as patient compliance, medication side effects and bone mineral density results rather than urinary NTX values.
    Original languageEnglish
    Pages (from-to)49-52
    JournalPathology
    Volume38
    Issue number1
    DOIs
    Publication statusPublished - 2006

    Fingerprint

    Tertiary Care Centers
    Osteoporosis
    Bone Density
    Patient Compliance
    Therapeutics
    Photon Absorptiometry
    Physiologic Monitoring
    Bone Resorption
    Hip
    Spine
    Enzyme-Linked Immunosorbent Assay
    Physicians

    Cite this

    @article{ee66001b03fe41449ccd311d34cf8b50,
    title = "Urinary NTX results rarely alter the clinical management of patients with osteoporosis in the tertiary hospital",
    abstract = "Aim: Urinary levels of cross-linked N-terminal telopeptide of type I collagen ( NTX) are used as a marker of bone resorption and are useful for monitoring response of patients treated with anti-resorptive agents. We aimed to determine how urinary NTX results alter clinical decision making by physicians treating patients with osteoporosis in a tertiary hospital setting.Methods: We reviewed patient notes of all new NTX requests in 2002 and 2003 with at least one subsequent repeat measurement. Patients with a diagnosis of osteoporosis and both pre- and post- treatment measurements of bone mineral density ( BMD) and NTX were included. Urinary NTX was measured with the Osteomark enzyme-linked immunosorbent assay. BMD of the hip and lumbar spine was measured using dual energy X-ray absorptiometry ( DEXA).Results: A total of 357 patients had serial NTX requests during the time period. Sixty-five of these patients had a diagnosis of osteoporosis. Out of 37 patients treated for osteoporosis who had complete data available, 29 patients had concordant results between BMD and NTX and eight patients had discordant results. Only one patient had treatment changed as a result of a lack of reduction in NTX following treatment. Thirteen patients had therapy altered. Common reasons for altering therapy were patient noncompliance, side effects and failure of BMD to increase.Conclusions: Alteration to therapy in this patient population is mainly dictated by issues such as patient compliance, medication side effects and bone mineral density results rather than urinary NTX values.",
    author = "M.J. Gillett and Samuel Vasikaran",
    year = "2006",
    doi = "10.1080/00313020500459623",
    language = "English",
    volume = "38",
    pages = "49--52",
    journal = "Pathology",
    issn = "0031-3025",
    publisher = "Pergamon",
    number = "1",

    }

    Urinary NTX results rarely alter the clinical management of patients with osteoporosis in the tertiary hospital. / Gillett, M.J.; Vasikaran, Samuel.

    In: Pathology, Vol. 38, No. 1, 2006, p. 49-52.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Urinary NTX results rarely alter the clinical management of patients with osteoporosis in the tertiary hospital

    AU - Gillett, M.J.

    AU - Vasikaran, Samuel

    PY - 2006

    Y1 - 2006

    N2 - Aim: Urinary levels of cross-linked N-terminal telopeptide of type I collagen ( NTX) are used as a marker of bone resorption and are useful for monitoring response of patients treated with anti-resorptive agents. We aimed to determine how urinary NTX results alter clinical decision making by physicians treating patients with osteoporosis in a tertiary hospital setting.Methods: We reviewed patient notes of all new NTX requests in 2002 and 2003 with at least one subsequent repeat measurement. Patients with a diagnosis of osteoporosis and both pre- and post- treatment measurements of bone mineral density ( BMD) and NTX were included. Urinary NTX was measured with the Osteomark enzyme-linked immunosorbent assay. BMD of the hip and lumbar spine was measured using dual energy X-ray absorptiometry ( DEXA).Results: A total of 357 patients had serial NTX requests during the time period. Sixty-five of these patients had a diagnosis of osteoporosis. Out of 37 patients treated for osteoporosis who had complete data available, 29 patients had concordant results between BMD and NTX and eight patients had discordant results. Only one patient had treatment changed as a result of a lack of reduction in NTX following treatment. Thirteen patients had therapy altered. Common reasons for altering therapy were patient noncompliance, side effects and failure of BMD to increase.Conclusions: Alteration to therapy in this patient population is mainly dictated by issues such as patient compliance, medication side effects and bone mineral density results rather than urinary NTX values.

    AB - Aim: Urinary levels of cross-linked N-terminal telopeptide of type I collagen ( NTX) are used as a marker of bone resorption and are useful for monitoring response of patients treated with anti-resorptive agents. We aimed to determine how urinary NTX results alter clinical decision making by physicians treating patients with osteoporosis in a tertiary hospital setting.Methods: We reviewed patient notes of all new NTX requests in 2002 and 2003 with at least one subsequent repeat measurement. Patients with a diagnosis of osteoporosis and both pre- and post- treatment measurements of bone mineral density ( BMD) and NTX were included. Urinary NTX was measured with the Osteomark enzyme-linked immunosorbent assay. BMD of the hip and lumbar spine was measured using dual energy X-ray absorptiometry ( DEXA).Results: A total of 357 patients had serial NTX requests during the time period. Sixty-five of these patients had a diagnosis of osteoporosis. Out of 37 patients treated for osteoporosis who had complete data available, 29 patients had concordant results between BMD and NTX and eight patients had discordant results. Only one patient had treatment changed as a result of a lack of reduction in NTX following treatment. Thirteen patients had therapy altered. Common reasons for altering therapy were patient noncompliance, side effects and failure of BMD to increase.Conclusions: Alteration to therapy in this patient population is mainly dictated by issues such as patient compliance, medication side effects and bone mineral density results rather than urinary NTX values.

    U2 - 10.1080/00313020500459623

    DO - 10.1080/00313020500459623

    M3 - Article

    VL - 38

    SP - 49

    EP - 52

    JO - Pathology

    JF - Pathology

    SN - 0031-3025

    IS - 1

    ER -